Author:
Martinelli Leonardo K. B.,Rotta Mariane,Villela Anne D.,Rodrigues-Junior Valnês S.,Abbadi Bruno L.,Trindade Rogério V.,Petersen Guilherme O.,Danesi Giuliano M.,Nery Laura R.,Pauli Ivani,Campos Maria M.,Bonan Carla D.,de Souza Osmar Norberto,Basso Luiz A.,Santos Diogenes S.
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. World Health Organization. Global Tuberculosis Report https://www.health-e.org.za/wp-content/uploads/2015/10/Global-TB-Report-2015-FINAL-2.pdf (2015).
2. Gandhi, N. R. et al. Multidrug resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. The Lancet 375, 1830–1843 (2010).
3. Pawlowski, A., Jansson, M., Sköld, M., Rottenberg, M. E. & Källenius, G. Tuberculosis and HIV co-infection. PLoS Pathog. 8(2), 1–7 (2012).
4. TB Alliance. Executive Summary of the Scientific Blueprint for TB Drug Development (2001).
5. Vilchèze, C. et al. Inactivation of the inhA-encoded Fatty Acid Synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis . J. Bacteriol. 182(14), 4059–4067 (2000).
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献